Vantage Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $249K | Sell |
3,227
-12
| -0.4% | -$926 | 0.05% | 135 |
|
|
2018
Q2 | $229K | Sell |
3,239
-302
| -9% | -$21.4K | 0.06% | 137 |
|
|
2018
Q1 | $267K | Hold |
3,541
| – | – | 0.07% | 125 |
|
|
2017
Q4 | $254K | Sell |
3,541
-78
| -2% | -$5.6K | 0.06% | 136 |
|
|
2017
Q3 | $293K | Sell |
3,619
-318
| -8% | -$25.7K | 0.08% | 119 |
|
|
2017
Q2 | $264K | Buy |
3,937
+236
| +6% | +$15.8K | 0.08% | 120 |
|
|
2017
Q1 | $251K | Sell |
3,701
-245
| -6% | -$16.6K | 0.08% | 118 |
|
|
2016
Q4 | $283K | Sell |
3,946
-23,407
| -86% | -$1.68M | 0.11% | 106 |
|
|
2016
Q3 | $2.16M | Buy |
27,353
+198
| +0.7% | +$15.7K | 0.96% | 36 |
|
|
2016
Q2 | $2.26M | Buy |
27,155
+50
| +0.2% | +$4.17K | 0.95% | 32 |
|
|
2016
Q1 | $2.49M | Buy |
27,105
+4,857
| +22% | +$446K | 1.1% | 29 |
|
|
2015
Q4 | $2.25M | Buy |
22,248
+3,447
| +18% | +$349K | 1.13% | 28 |
|
|
2015
Q3 | $1.85M | Buy |
18,801
+3,114
| +20% | +$306K | 1.04% | 30 |
|
|
2015
Q2 | $1.84M | Sell |
15,687
-10,300
| -40% | -$1.21M | 1.01% | 28 |
|
|
2015
Q1 | $2.55M | Buy |
25,987
+13,168
| +103% | +$1.29M | 0.72% | 40 |
|
|
2014
Q4 | $1.21M | Buy |
12,819
+1,919
| +18% | +$181K | 0.68% | 39 |
|
|
2014
Q3 | $1.16M | Buy |
10,900
+5,899
| +118% | +$628K | 0.7% | 39 |
|
|
2014
Q2 | $415K | Buy |
5,001
+1,535
| +44% | +$127K | 0.25% | 69 |
|
|
2014
Q1 | $246K | Buy |
3,466
+690
| +25% | +$49K | 0.16% | 92 |
|
|
2013
Q4 | $208K | Buy |
+2,776
| New | +$208K | 0.14% | 101 |
|